Manju Koli

Manju Koli

Auto-generated profile, based on publicly available information

Manju Koli

Assistant Professor, Invertis Institute of Pharmacy, Invertis University, Bareilly, Uttar Pradesh, 243123, India

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2024 in Journal of Drug Delivery and Therapeutics
Verified
Journal Article
Open access
PDF file
RPRahul Pal
Rahul Pal
PPPrachi Pandey
Prachi Pandey
MKManju Koli
Manju Koli
KSKhushi Srivastava
Khushi Srivastava
VTVaisanavi Tiwari
Vaisanavi Tiwari
PDProttay Dutta
Prottay Dutta
This comprehensive review aims to explore the future potential of nasopulmonary drug delivery systems for the administration of drugs through the nasal route. Nasal drug delivery has gained significant attention due to its numerous advantages, including rapid absorption, avoidance of first-pass metabolism, and non-invasive administration. This review provides an overview of the nasal anatomy and physiology, highlighting the factors influencing drug absorption and bioavailability. Additionally, it discusses the various types of nasopulmonary drug delivery systems, such as nasal sprays, powders, and gels, along with their advantages and limitations. Furthermore, the review delves into the challenges associated with nasal drug delivery, including mucociliary clearance, nasal irritation, and formulation issues. The potential applications of nasopulmonary drug delivery systems in the treatment of various diseases, such as allergies, respiratory disorders, and systemic conditions, are also discussed. Finally, the review concludes with an outlook on the future prospects of nasopulmonary drug delivery systems, emphasising the need for further research and development to optimise their efficacy and safety. Keywords: nasal pulmonary; nasal spray; nasal mucosa; gels; drops; nasal approaches; nasal route; nasal delivery.

15 March 2024 in Journal of Drug Delivery and Therapeutics
Verified
Journal Article
Open access
PDF file
PPPrachi Pandey
Prachi Pandey
RPRahul Pal
Rahul Pal
MKManju Koli
Manju Koli
RMRaj Kumar Malakar
Raj Kumar Malakar
SVSandeep Verma
Sandeep Verma
PKPavan Kumar
Pavan Kumar
Nutraceuticals refer to food products that have a positive impact on the well-being of individuals. This category includes dietary supplements, herbal products, probiotics, and prebiotics, as well as medical foods designed for disease prevention and treatment. The nutraceutical market is witnessing substantial growth worldwide, primarily due to the growing awareness among consumers about the connection between diet and health. Additionally, there is a rising demand for functional foods and dietary supplements. As consumers prioritize preventive healthcare, they are increasingly looking for products that provide targeted health benefits beyond basic nutrition. The rise of this trend can be attributed to various factors, including the aging population, rising healthcare expenses, and a preference for natural and organic ingredients. Nutraceuticals, as a major force in the industry, offer numerous beneficial effects with minimal undesirable impacts, thus attracting more consumer interest. The increasing shift towards preventive treatments, along with the growth in disposable income and a positive market outlook for the pharmaceutical sector, has primarily contributed to the expanding nutraceutical market in India. However, challenges such as the lack of regulation and awareness, high pricing, marketing, and distribution issues need to be addressed. Nutraceutical market is seeing flowing development chiefly in United States, India, and European nations. This review article primarily focuses on providing a concise overview of nutraceuticals, categorizing them, and discussing their significant roles in various health conditions. Additionally, it delves into the present and future status of nutraceuticals on a global scale. Keywords: traditional cure; nutraceuticals; remedy; prebiotics; probiotics; regulatory compliance; supplementary diets; nutraceutical ingredients.

13 November 2025 in Current Nanomedicine
Verified
Journal Article
Closed access
MKManju Koli
Manju Koli
TSTapaskumar Mukeshkumar Shah
Tapaskumar Mukeshkumar Shah
PDProttay Dutta
Prottay Dutta
NPNeetu Patel
Neetu Patel
APAbhay Kumar Patel
Abhay Kumar Patel
RPRahul Pal
Rahul Pal
Niosomes (Niosomes), as Non-Ionic Surfactant (NIOs)-based vesicles, have emerged as versatile nanocarriers in the targeted delivery of drugs due to their biocompatibility, chemical stability, and ability to encapsulate both hydrophilic and lipophilic drugs. Their utility has gained significant traction in addressing challenges associated with conventional therapies, for chronic and resistant diseases, Tuberculosis (TB), and cancer. This review critically evaluates the role of NIOs in the formulation of Niosomes, emphasizing their influence on clinical efficacy, pharma-cokinetics, and targeted drug delivery. It also explores the emerging patent landscape and transla-tional potential of Niosomes systems in TB and oncology. A comprehensive literature and patent database search was conducted using PubMed, Google Scholar, ScienceDirect, Scopus, Elsevier, SpringerLink, and ClinicalTrials.gov, as well as Google Patents, USPTO, and WIPO, covering publications and patents from 20202025 onwards. The relevant studies, clinical trials, and granted patents involving Niosomes formulations with NIOs were systematically analyzed for their for-mulation design, therapeutic outcomes, and disease-specific applications. The study showed a no-table rise in research and patents on Niosomes drug delivery using NIOs categories. In TB, these systems enhanced Bioavailability (BA), sustained drug release, and targeted macrophages. In cancer therapy, they enabled controlled release, minimized side effects, and improved tumor tar-geting. The recent patents highlight advances in combination therapies, responsive systems, and ligand-based targeting, reflecting a trend toward personalized medicine. NIOs play a critical role in modulating the performance of Niosomes drug carriers. Their strategic application in TB and oncology represents a promising avenue for improving therapeutic outcomes. Continued research and innovation in this field, as reflected by patent trends, highlight the translational potential of NIO-based Niosomes formulations toward clinical use.

9 September 2025
Verified
Book
Open access
PDF file
RPRahul Pal
Rahul Pal
Binita GhoshBinita Ghosh
Binita Ghosh
MKManju Koli
Manju Koli
PDProttay Dutta
Prottay Dutta
It is with immense pride and gratitude that I present this edited volume, “Next-Gen Nanomedicine for Breast Cancer: From Bench to Bedside and Beyond.” This book brings together the collective efforts of researchers, clinicians, and academicians working at the interface of nanotechnology and oncology, aiming to illuminate the path toward more effective, targeted, and patient-friendly therapeutic strategies for breast cancer. The vision behind this book has always been to bridge the gap between fundamental research and clinical application. Nanomedicine has emerged as one of the most promising frontiers in modern science, and its role in revolutionizing breast cancer management cannot be overstated. Each chapter reflects the dedication and insight of experts in the field, offering readers not only cutting-edge scientific knowledge but also a glimpse into the future of personalized medicine.